Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy

Journal of Clinical Oncology

Volumn 17, Issue 8, 1999, Pages 2514-2520

  Pisters, Louis L ^a   Perrotte, Paul ^a   Scott, Shellie M ^a   Greene, Graham F ^a   von Eschenbach, Andrew C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CRYOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SALVAGE THERAPY; TREATMENT FAILURE; TUMOR BIOPSY;

EID: 0032772765     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.8.2514     Document Type: Article

References (26)

1. Zagars GK, Pollack A, von Eschenbach AC: Prostate cancer and radiation therapy-the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 33:23-35, 1995
2. Pollack A, Zagars GK, Kavadi VS: Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer 74:670-678, 1994
3. Lee WR, Hanks GE, Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J Clin Oncol 15:230-238, 1997
4. Hanks GE, Martz KL, Krall JM, et al: Analysis of independent variables affecting survival after recurrence of prostate cancer. Int J Radiat Oncol Biol Phys 16:1431-1435, 1989
5. Wheeler JA, Zagars GK, Ayala AG: Dedifferentiation of locally recurrent prostate cancer after radiation therapy: Evidence for tumor progression. Cancer 71:3783-3787, 1993
6. Younes E, Haas GP, Montie JE, et al: Value of preoperative PSA in predicting pathologic stage of patients undergoing salvage prostatectomy. Urology 43:22-25, 1994
7. Lerner SE, Blute ML, Zincke H: Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol 154:1103-1109, 1995
8. Rogers E, Ohori M, Kassabian VS, et al: Salvage radical prostatectomy: Outcome measured by serum prostate specific antigen levels. J Urol 153:104-110, 1995
9. Pisters LL, von Eschenbach AC, Scott SM, et al: The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157:921-925, 1997
10. Link P, Freiha FS: Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology 37:189-192, 1991
11. Stein A, Smith RB, deKernion JB: Salvage radical prostatectomy after failure of curative radiotherapy for adenocarcinoma of prostate. Urology 40:197-200, 1992
12. Neerhut GJ, Wheeler T, Cantini M, et al: Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate. J Urol 140:544-549, 1988
13. Moul JW, Paulson DF: The role of radical surgery in the management of radiation recurrent and large volume prostate cancer. Cancer 68:1265-1271, 1991
14. Milam DF, Franke JJ: Prevention and treatment of incontinence after radical prostatectomy. Semin Urol Oncol 13:224-237, 1995
15. Martins FE, Bennett CJ, Dunn M, et al: Adverse prognostic features of collagen injection therapy for urinary incontinence following radical retropubic prostatectomy. J Urol 158:1745-1749, 1997
16. Martins FE, Boyd SD: Post-operative risk factors associated with artificial urinary sphincter infection-erosion. Br J Urol 75:354-358, 1995
17. Gleason D: Histologic grading and clinical staging of prostatic carcinoma, in Tannenbaum M (ed): Urologic Pathology: The Prostate. Philadelphia, PA, Lea and Febiger, 1977, pp 171-197
18. Stamey TA, McNeal JE, Yemoto CM, et al: Gleason sums of 7 lose valuable prognostic information in comparison to estimates of % grade 4 and 5 cancer. J Urol 157:204A, 1997 (abstr 794)
19. Dugan TC, Shipley WU, Young RH, et al: Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: Correlation with original histological grade and current prostate specific antigen levels. J Urol 146:1313-1316, 1991
20. Zagars GK, Johnson DE, von Eschenbach AC, et al: Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Long-term results of a prospective randomized study. Int J Radiat Oncol Biol Phys 14:1085-1091, 1988
21. Fellows GJ, Clark PB, Beynon LL, et al: Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council Study. Br J Urol 70:304-309, 1992
22. Bolla M, Gonzalez D, Warde P, et al: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295-300, 1997
23. Greene GF, Pisters LL, Scott SM, et al: Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol 160:86-90, 1998
24. Shinohara K, Rhee B, Presti JC, Jr, et al: Cryosurgical ablation of prostate cancer: Patterns of cancer recurrence. J Urol 158:2206-2209, 1997
25. Scardino PT, Frankel JM, Wheeler TM, et al: The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. J Urol 135:510-516, 1986
26. Zagars GK, Pollack A, Kavadi VS, et al: Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 32:293-306, 1995